NeuroPace Inc
Company Stats
- Market Cap
- $472.3M
- as of Sep 30, 2026
- Shares Outstanding
- 34.3M
- Free Float
- 58.1%
Income Statement
- Revenue
- $100.0M
- Operating Income
- -$16.3M
- Net Income
- -$21.5M
- EBITDA
- -$16.1M
- Revenue Growth, 3Y
- 30.0%
- FCF Margin, 3Y Avg
- -21.5%
- FCF Margin, Worst Year
- -30.4%
Cash Flow
- Free Cash Flow
- -$11.3M
- FCF Yield
- -2.4%
- Owner FCF Yield
- -4.7%
Balance Sheet
- Cash & Equivalents
- $21.7M
Returns & Capital
- Share Repurchases
- $49.5M
- SBC, 3Y Avg
- $10.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $100.0M | -$11.3M | -11.3% |
| FY2024 | $79.9M | -$18.3M | -22.8% |
| FY2023 | $65.4M | -$19.9M | -30.4% |
| FY2022 | $45.5M | -$37.5M | -82.3% |
| FY2021 | $45.2M | -$25.0M | -55.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges